Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... Cyclophosphamide Mycophenolate Mofetil Phase:  ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  2. Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

    ... with tacrolimus and methotrexate compared to tacrolimus, mycophenolate mofetil and a reduced-dose methotrexate in patients with hematologic ... MMF 45 mg/kg/day (15mg/kg IV three times a day). Other Names: Cellcept MMF Drug: Methotrexate (low dose) MTX 5mg/m2 IV on day +1, +3, ...

    Clinical Trial last updated 04/29/2016 - 2:26pm.

  3. Intra-Osseous Co-Transplant of UCB and hMSC

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil at the time of transplant may stop this from happening. ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  4. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... fludarabine phosphate (FLU), cyclosporine (CSP), mycophenolate mofetil (MMF), or sirolimus before transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  5. Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil after transplant may stop this from happening. ...

    Clinical Trial last updated 04/29/2016 - 1:56pm.

  6. Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

    ... the body's normal cells. Giving cyclosporine and mycophenolate mofetil after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 12:13pm.

  7. Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    ... irradiation, donor bone marrow transplant , mycophenolate mofetil, and tacrolimus in treating patients with hematologic cancer. Giving ...

    Clinical Trial last updated 04/29/2016 - 12:48pm.

  8. Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

    ... Fludarabine Mycophenolate Mofetil Phase:  ...

    Clinical Trial last updated 04/29/2016 - 12:58pm.

  9. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... graft-versus-host disease). Giving cyclosporine and mycophenolate mofetil before and after transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  10. Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Sy

    ... body's normal cells. Giving cyclophosphamide together with mycophenolate mofetil and tacrolimus after the transplant may stop this from happening. ...

    Clinical Trial last updated 04/28/2016 - 1:01pm.